Ed. Clarkson et al., GDNF IMPROVES SURVIVAL AND REDUCES APOPTOSIS IN HUMAN EMBRYONIC DOPAMINERGIC-NEURONS IN-VITRO, Cell and tissue research, 289(2), 1997, pp. 207-210
Dopamine cell death is the primary problem limiting the value of neuro
transplantation in human patients with Parkinson's disease. To address
this problem, we added glial cell line-derived neurotrophic factor (G
DNF) to cultures of embryonic dopaminergic neurons obtained from human
and from Bonnet monkey (Macaca radiata) in an effort to reduce apopto
tic cell death and improve overall cell survival. Tissue from three hu
man embryos, 7-8 weeks post-conception, and one 9-week post-conception
monkey embryo were dissociated and cultured in F-12 media with 5% hum
an placental serum. GDNF (10 ng/ml) in human cultures nearly doubled d
opamine neuron survival and reduced the rate of apoptosis from 6% to 3
%. In monkey cultures, GDNF also enhanced dopamine neuron survival and
reduced the apoptotic rate. We conclude that GDNF improves the surviv
al of primate embryonic dopamine neurons in culture by reducing apopto
sis.